Identification and validation of a novel risk model based on cuproptosis-associated m6A for head and neck squamous cell carcinoma

被引:0
|
作者
Xing, Zhongxu [1 ]
Xu, Yijun [1 ]
Xu, Xiaoyan [1 ]
Yang, Kaiwen [1 ]
Qin, Songbing [1 ]
Jiao, Yang [2 ]
Wang, Lili [1 ]
机构
[1] Soochow Univ, Dept Radiat Oncol, Affiliated Hosp 1, Suzhou 21500, Peoples R China
[2] Soochow Univ, Collaborat Innovat Ctr Radiol Med Jiangsu Higher E, Sch Radiat Med & Protect, State Key Lab Radiat Med & Protect, Suzhou 215123, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
Head and neck squamous cell carcinoma; RNA methylation regulation; Cuproptosis; Prognosis; Risk model; TUMOR MICROENVIRONMENT; IMMUNE ESCAPE; EXPRESSION; REGULATORS; LANDSCAPE; BURDEN; PD-L1;
D O I
10.1186/s12920-024-01916-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Head and neck squamous cell carcinoma (HNSCC) is a prevalent cancer with a poor survival rate due to anatomical limitations of the head and a lack of reliable biomarkers. Cuproptosis represents a novel cellular regulated death pathway, and N6-methyladenosine (m6A) is the most common internal RNA modification in mRNA. They are intricately connected to tumor formation, progression, and prognosis. This study aimed to construct a risk model for HNSCC using a set of mRNAs associated with m6A regulators and cuproptosis genes (mcrmRNA).Methods RNA-seq and clinical data of HNSCC patients from The Cancer Genome Atlas (TCGA) database were analyzed to develop a risk model through the least absolute shrinkage and selection operator (LASSO) analysis. Survival analysis and receiver operating characteristic (ROC) analysis were performed for the high- and low-risk groups. Additionally, the model was validated using the GSE41613 dataset from the Gene Expression Omnibus (GEO) database. GSEA and CIBERSORT were applied to investigate the immune microenvironment of HNSCC.Results A risk model consisting of 32 mcrmRNA was developed using the LASSO analysis. The risk score of patients was confirmed to be an independent prognostic indicator by multivariate Cox analysis. The high-risk group exhibited a higher tumor mutation burden. Additionally, CIBERSORT analysis indicated varying levels of immune cell infiltration between the two groups. Significant disparities in drug sensitivity to common medications were also observed. Enrichment analysis further unveiled significant differences in metabolic pathways and RNA processing between the two groups.Conclusions Our risk model can predict outcomes for HNSCC patients and offers valuable insights for personalized therapeutic approaches.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Identification and development of a novel risk model based on cuproptosis-associated RNA methylation regulators for predicting prognosis and characterizing immune status in hepatocellular carcinoma
    Duguang Li
    Zhaoqi Shi
    Xiaolong Liu
    Shengxi Jin
    Peng Chen
    Yiyin Zhang
    Guoqiao Chen
    Xiaoxiao Fan
    Jing Yang
    Hui Lin
    Hepatology International, 2023, 17 : 112 - 130
  • [22] Cuproptosis-related LncRNA signatures as a prognostic model for head and neck squamous cell carcinoma
    Qing Sun
    Xuemei Qin
    Jing Zhao
    Tianle Gao
    Yinwei Xu
    Guohui Chen
    Guangping Bai
    Zhiqiang Guo
    Jian Liu
    Apoptosis, 2023, 28 : 247 - 262
  • [23] Validation of the Histologic Risk Model in a New Cohort of Patients With Head and Neck Squamous Cell Carcinoma
    Brandwein-Gensler, Margaret
    Smith, Richard V.
    Wang, Beverly
    Penner, Carla
    Theilken, Andrea
    Broughel, Darcy
    Schiff, Bradley
    Owen, Randall P.
    Smith, Jonathan
    Sarta, Cathy
    Hebert, Tiffany
    Nason, Rick
    Ramer, Marie
    DeLacure, Mark
    Hirsch, David
    Myssiorek, David
    Heller, Keith
    Prystowsky, Michael
    Schlecht, Nicolas F.
    Negassa, Abdissa
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (05) : 676 - 688
  • [24] Cuproptosis-related LncRNA signatures as a prognostic model for head and neck squamous cell carcinoma
    Sun, Qing
    Qin, Xuemei
    Zhao, Jing
    Gao, Tianle
    Xu, Yinwei
    Chen, Guohui
    Bai, Guangping
    Guo, Zhiqiang
    Liu, Jian
    APOPTOSIS, 2023, 28 (1-2) : 247 - 262
  • [25] The m6A reader protein YTHDC2 is a potential biomarker and associated with immune infiltration in head and neck squamous cell carcinoma
    Li, Yang
    Zheng, Ji-Na
    Wang, En-Hao
    Gong, Chan-Juan
    Lan, Keng-Fu
    Ding, XiaoJun
    PEERJ, 2020, 8
  • [26] Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck
    Wreesmann, VB
    Shi, W
    Thaler, HT
    Poluri, A
    Kraus, DH
    Pfister, D
    Shaha, AR
    Shah, JP
    Rao, PH
    Singh, B
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) : 3965 - 3972
  • [27] Novel Prognostic Model Based on Immune Signature for Head and Neck Squamous Cell Carcinoma
    Wang, Yingying
    Xu, Yu
    Hua, Qingquan
    Jiang, Yang
    Liu, Peiqiang
    Zhang, Wei
    Xiang, Rong
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [28] Identification of a novel cuproptosis-associated lncRNA model that can improve prognosis prediction in uterine corpus endometrial carcinoma
    Li, Bohan
    Li, Xiaoling
    Ma, Mudan
    Shi, Jie
    Wu, Chao
    HELIYON, 2023, 9 (12)
  • [29] Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes
    Ren, Ziying
    Zhang, Long
    Ding, Wei
    Luo, Yilang
    Shi, Zhiqiang
    Shrestha, Bikal
    Kan, Xuan
    Zhang, Zhuhua
    Ding, Jing
    He, Haojie
    Hu, Xuegang
    GENOMICS, 2021, 113 (01) : 1166 - 1175
  • [30] Identification of two molecular subtypes and a novel prognostic model of lung adenocarcinoma based on a cuproptosis-associated gene signature
    Zhou, Jinlin
    Chen, Dehe
    Zhang, Shiguo
    Wang, Chunmei
    Zhang, Li
    FRONTIERS IN GENETICS, 2023, 13